Analgesic effect of parecoxib and flurbiprofen axetil for patients undergoing laparoscopic cholecystectomy and their influences on platelet aggregation

Chinese Medical Journal

Volumn 123, Issue 12, 2010, Pages 1607-1609

  Ji, Fu Hai ^a   Jin, Xin ^a   Yang, Jian Ping ^a   Zan, Li Li ^b  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SUZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

Analgesia; Cyclooxygenase inhibitor; Flurbiprofen axetil; Parecoxib

Indexed keywords

FENTANYL; FLURBIPROFEN AXETIL; PARECOXIB; PETHIDINE; REMIFENTANIL;

ANALGESIC ACTIVITY; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; BLOOD SAMPLING; CHOLECYSTECTOMY; CLINICAL ARTICLE; DOUBLE BLIND PROCEDURE; HEART RATE; HUMAN; INTRAVENOUS ANESTHESIA; LAPAROSCOPIC SURGERY; OPERATION DURATION; OXYGEN SATURATION; PAIN; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; VISUAL ANALOG SCALE;

ANALGESIA; CHOLECYSTECTOMY, LAPAROSCOPIC; FEMALE; FLURBIPROFEN; HUMANS; ISOXAZOLES; MALE; PLATELET AGGREGATION;

EID: 79851469553     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.12.023     Document Type: Article

References (14)

1. Wang C, Liu JL, Sang HF, Lu Y, Dong HL, Xiong LZ. Therapeutic time window of flurbiprofen axetil's neuroprotective effect in a rat model of transient focal cerebral ischemia. Chin Med J 2008; 121: 2572-2577.
2. Ohmukai O. Lipo-NSAID preparation. Adv Drug Deliv Rev 1996; 20: 203-207.
3. Colanardi MC, Nettis E, Traetta P, Daprile C, Fitto C, Aloia AM, et al. Safety of parecoxib in patients with nonsteroidal anti-inflammatory drug-induced urticaria or angioedema. Ann Allergy Asthma Immunol 2008; 100: 82-85.
4. Moodley I. Review of the cardiovascular safety of COXIBs compared to NSAIDS. Cardiovasc J Afr 2008; 19: 102-107.
5. Yamazaki E, Murao K, Asai T, Matsumoto S, Shingu K. Comparison of analgesic effects of intravenous flurbiprofen and suppository indomethacin after laparoscopic cholecystectomy. Masui 2003; 52: 1186-1190.
6. Jones SJ, Cormack J, Murphy MA, Scott DA. Parecoxib for analgesia after craniotomy. Br J Anaesth 2009; 102: 76-79.
7. Gajraj NM. COX-2 inhibitors celecoxib and parecoxib: valuable options for postoperative pain management. Curr Top Med Chem 2007; 7: 235-249.
8. Scharbert G, Gebhardt K, Sow Z, Duris M, Deusch E, Kozek-Langenecker S. Point-of-care platelet function tests: detection of platelet inhibition induced by nonopioid analgesic drugs. Blood Coagul Fibrinolysis 2007; 18: 775-780.
9. Graff J, Arabmotlagh M, Cheung R, Geisslinger G, Harder S. Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: a double-blind, randomized, parallel-group study. Clin Ther 2007; 29: 438-447.
10. Terán-Estrada L, Miranda-Limón JM, Galván-Villegas F. Cardiovascular risk of cyclooxygenase selective inhibitors. Rev Med Inst Mex Seguro Soc 2008; 46: 287-299.
11. Tacconelli S, Francesco LD, Petrelli M, Patrignani P. Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outs. Expert Opin Drug Saf 2008; 7: 29-42.
12. Schug SA, Joshi GP, Camu F, Pan S, Cheung R. Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting: an analysis of integrated data. Anesth Analg 2009; 108: 299-307.
13. Straino S, Salloum FN, Baldi A, Ockaili RA, Piro M, Das A, et al. Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat. J Cardiovasc Pharmacol 2007; 50: 571-577.
14. Bijlsma JW, Lems WF, van de Laar MA. Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain. Ned Tijdschr Geneeskd 2007; 151: 795-798.